GSK PLC (GLAXF)
22.75
+0.64
(+2.87%)
USD |
OTCM |
May 22, 16:00
GSK Shareholders Equity (Quarterly): 17.47B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.47B |
December 31, 2023 | 17.00B |
September 30, 2023 | 16.02B |
June 30, 2023 | 16.01B |
March 31, 2023 | 14.64B |
December 31, 2022 | 12.83B |
September 30, 2022 | 10.22B |
June 30, 2022 | 19.86B |
March 31, 2022 | 21.26B |
December 31, 2021 | 20.32B |
September 30, 2021 | 20.71B |
June 30, 2021 | 21.28B |
March 31, 2021 | 20.43B |
December 31, 2020 | 19.88B |
September 30, 2020 | 18.38B |
June 30, 2020 | 16.73B |
March 31, 2020 | 16.20B |
December 31, 2019 | 14.95B |
September 30, 2019 | 14.47B |
June 30, 2019 | 4.580B |
March 31, 2019 | 5.235B |
December 31, 2018 | 4.798B |
September 30, 2018 | 5.832B |
June 30, 2018 | 4.810B |
March 31, 2018 | -96.70M |
Date | Value |
---|---|
December 31, 2017 | -91.90M |
September 30, 2017 | 1.738B |
June 30, 2017 | 1.055B |
March 31, 2017 | 2.139B |
December 31, 2016 | 1.381B |
September 30, 2016 | 178.89M |
June 30, 2016 | 772.70M |
March 31, 2016 | 4.035B |
December 31, 2015 | 7.576B |
September 30, 2015 | 8.230B |
June 30, 2015 | 10.72B |
March 31, 2015 | 11.01B |
December 31, 2014 | 6.635B |
September 30, 2014 | 8.190B |
June 30, 2014 | 10.42B |
March 31, 2014 | 11.01B |
December 31, 2013 | 11.54B |
September 30, 2013 | 9.658B |
June 30, 2013 | 9.781B |
March 31, 2013 | 10.17B |
December 31, 2012 | 9.373B |
September 30, 2012 | 10.10B |
June 30, 2012 | 10.94B |
March 31, 2012 | 14.00B |
December 31, 2011 | 12.38B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.580B
Minimum
Jun 2019
21.28B
Maximum
Jun 2021
16.66B
Average
16.87B
Median
Shareholders Equity (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 24.38M |
Biodexa Pharmaceuticals Plc | 5.959M |
Verona Pharma PLC | 224.99M |
NuCana PLC | 12.79M |
Autolus Therapeutics PLC | 582.03M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 73.87B |
Total Liabilities (Quarterly) | 57.17B |
Debt to Equity Ratio | 1.284 |
Current Ratio | 0.8669 |
Net Debt Paydown Yield | 0.40% |